Premium Brands Holdings Corporation (TSX:PBH)
Canada · Delayed Price · Currency is CAD 93.66
+0.16 (0.17%)
Aug 12, 2025, 4:00 PM EDT
CTI BioPharma Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 28, 2025 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 25, 2021 | Dec '20 Dec 26, 2020 | 2016 - 2020 |
| 6,900 | 6,471 | 6,261 | 6,030 | 4,932 | 4,069 | Upgrade | |
Revenue Growth (YoY) | 8.42% | 3.35% | 3.83% | 22.27% | 21.20% | 11.49% | Upgrade |
Cost of Revenue | 5,571 | 5,178 | 5,053 | 4,926 | 4,030 | 3,289 | Upgrade |
Gross Profit | 1,329 | 1,293 | 1,208 | 1,104 | 901.9 | 780.2 | Upgrade |
Selling, General & Admin | 764.5 | 752.1 | 710.2 | 661.3 | 524.9 | 469.9 | Upgrade |
Operating Expenses | 996 | 975.3 | 915.5 | 848.8 | 661.8 | 603.1 | Upgrade |
Operating Income | 332.7 | 317.3 | 292.9 | 254.9 | 240.1 | 177.1 | Upgrade |
Interest Expense | -205.4 | -199.3 | -177.3 | -105.9 | -60.1 | -57.5 | Upgrade |
Interest & Investment Income | 57.5 | 53.2 | 60.9 | 61.8 | 53.7 | 2.3 | Upgrade |
Earnings From Equity Investments | -60.5 | -39.7 | -22.5 | -15.8 | -7.8 | -2 | Upgrade |
Other Non Operating Income (Expenses) | 43.1 | 41.6 | -11.7 | 15.6 | -30.9 | 2.8 | Upgrade |
EBT Excluding Unusual Items | 167.4 | 173.1 | 142.3 | 210.6 | 195 | 122.7 | Upgrade |
Merger & Restructuring Charges | -5.3 | -5.8 | -4.4 | -6.2 | -7.7 | -5.6 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | -2.5 | 3.9 | - | - | Upgrade |
Other Unusual Items | -19.4 | 1.1 | -2.2 | -6.8 | -3.1 | -6.5 | Upgrade |
Pretax Income | 142.7 | 168.4 | 133.2 | 201.5 | 184.2 | 110.6 | Upgrade |
Income Tax Expense | 49.5 | 46.9 | 39 | 41.4 | 51.5 | 26.9 | Upgrade |
Earnings From Continuing Operations | 93.2 | 121.5 | 94.2 | 160.1 | 132.7 | 83.7 | Upgrade |
Net Income to Company | 93.2 | 121.5 | 94.2 | 160.1 | 132.7 | 83.7 | Upgrade |
Net Income | 93.2 | 121.5 | 94.2 | 160.1 | 132.7 | 83.7 | Upgrade |
Net Income to Common | 93.2 | 121.5 | 94.2 | 160.1 | 132.7 | 83.7 | Upgrade |
Net Income Growth | -17.67% | 28.98% | -41.16% | 20.65% | 58.54% | -0.59% | Upgrade |
Shares Outstanding (Basic) | 45 | 44 | 44 | 45 | 44 | 39 | Upgrade |
Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 44 | 39 | Upgrade |
Shares Change (YoY) | 0.34% | - | -0.45% | 2.52% | 12.05% | 8.33% | Upgrade |
EPS (Basic) | 2.09 | 2.74 | 2.12 | 3.59 | 3.05 | 2.16 | Upgrade |
EPS (Diluted) | 2.08 | 2.72 | 2.11 | 3.57 | 3.04 | 2.15 | Upgrade |
EPS Growth | -18.20% | 28.91% | -40.90% | 17.43% | 41.39% | -8.12% | Upgrade |
Free Cash Flow | -137.3 | -111.7 | 34.2 | -131.9 | -76.9 | 134.7 | Upgrade |
Free Cash Flow Per Share | -3.07 | -2.50 | 0.77 | -2.94 | -1.76 | 3.45 | Upgrade |
Dividend Per Share | 3.400 | 3.400 | 3.080 | 2.800 | 2.540 | 2.310 | Upgrade |
Dividend Growth | 4.94% | 10.39% | 10.00% | 10.24% | 9.96% | 10.00% | Upgrade |
Gross Margin | 19.26% | 19.98% | 19.30% | 18.30% | 18.29% | 19.18% | Upgrade |
Operating Margin | 4.82% | 4.90% | 4.68% | 4.23% | 4.87% | 4.35% | Upgrade |
Profit Margin | 1.35% | 1.88% | 1.50% | 2.66% | 2.69% | 2.06% | Upgrade |
Free Cash Flow Margin | -1.99% | -1.73% | 0.55% | -2.19% | -1.56% | 3.31% | Upgrade |
EBITDA | 451.6 | 430.9 | 392.7 | 363.2 | 337.4 | 270.5 | Upgrade |
EBITDA Margin | 6.54% | 6.66% | 6.27% | 6.02% | 6.84% | 6.65% | Upgrade |
D&A For EBITDA | 118.9 | 113.6 | 99.8 | 108.3 | 97.3 | 93.4 | Upgrade |
EBIT | 332.7 | 317.3 | 292.9 | 254.9 | 240.1 | 177.1 | Upgrade |
EBIT Margin | 4.82% | 4.90% | 4.68% | 4.23% | 4.87% | 4.35% | Upgrade |
Effective Tax Rate | 34.69% | 27.85% | 29.28% | 20.55% | 27.96% | 24.32% | Upgrade |
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.